MNKD
MannKind Corporation
NASDAQ · Healthcare · Biotechnology · US
$4.06
+2.53%Margins
Gross margin
75.7%
EBITDA margin
7.8%
EBIT margin
2.0%
Net margin
-11.1%
FCF margin
-4.7%
64.9%
Return on equity
-6.0%
Return on assets
2.9%
Return on invested capital
0.53x
Asset turnover
-$8.5M
Cash from operations
$0.35
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026